Want to drive the Lamborghini that Batman drives in his latest movie flick, Dark Knight? Well, Gujarat&rsquo;s rich and swanky would have to wait for 18 months to get one in their driveway. Such is the demand of the car, that the company will not be able to make any deliveries of the Aventador in the country this year, while it already has a booking for 30 cars. The Gellardo, on the other hand, has a five to six months waiting.

Batmobile Lamborghini holds first sales meet in Guj

Business Standard

Ahmedabad-based privately held pharma company Cadila Pharmaceuticals Ltd has decided to go slow on its plans to come up with a manufacturing plant at Rwanda in partnership with US based Holtzman Group.

Cadila puts Rwanda project on hold

As getting approvals for clinical trials gets tedious and time consuming with the New Drug Advisory Committee (NDAC) taking charge, clinical research organisations (CROs) have taken a hit in overall profitability.While some are turning to south-east Asian geographies to offset the losses incurred in India, others are increasing focus on data-management services. Industry insiders say the business growth has already started shrinking by 20-30 per cent compared to last year.

Delay in approvals add to clinical research firms&#39; woes

Amidst dwindling sales and dealerships downing shutters, e-bike makers are devising strategies to stay afloat in these challenging times.

With dwindling sales E-bike makers devise strategies to stay afloat

Taking a cue from the boom in the e-commerce industry in India, direct selling companies have also started leveraging the power of the online platform to sell their products to their business owners.

Direct selling Cos bank on e-commerce to generate biz

Small scale pharmaceutical companies in Gujarat fail to rake in the moolah through higher export sales realisation as the rupee depreciates. Reason being, major export markets for these units are the non-dollar economies like the African countries. As their overseas clients in these developing countries too are hit by currency fluctuations, demand for drugs has failed to pick up.

Weak Rupee fails to cheer small pharma firms in Guj

Now Maharashtra, Kerala, Karnataka, Andhra Pradesh and Goa would follow Gujarat's model of issuing online product licenses in the bulk drug segment.

Maha, Kerala, keen to follow Gujarat model of online drug licenses

City-based mid-sized pharma player Unimark Remdies has altered its earlier product pipeline of producing an anti-hypertension and anti-cholesterol drug, to focus on developing the active pharmaceutical ingredients (API) of a widely selling anti-biotic amoxycillin through the biocatalysis process.

Unimark alters product pipeline to focus on antibiotic API

Guj-based Unimark alters product pipeline 

With dwindling sales, e-bike makers devise strategises to stay afloat

For the second time in a month, a complaint of infringement of patent has been filed against Zydus Pharmaceuticals (USA), a wholly-owned subsidiary of Ahmedabad-based pharma major Cadila Health-care (Zydus Cadila) at a US district court.

Pfizer complains against Zydus on US patent violation 

Fall in international crude prices has failed to offer any respite to the plastic processors in the state. The industry says that while crude is down by almost 25 per cent from the peak period, in comparison, polymer prices have slipped by only 4-5 per cent. This, coupled with foreign exchange losses as well as plummeting demand, has, in turn, started affecting the profitability of the plastic players, forcing a few hundred small and tiny processors to shut shop.

Sohini Das